Medibio Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medibio Ltd with three other
pharmaceutical manufacturers in Australasia:
Cann Global Ltd
(2021
sales of 1.65 million Australian Dollars [US$1.20 million]
),
Prescient Therapeutics Ltd
(66,285.00 Australian Dollars [US$48,032.76 ]
of which 100%
was Clinical stage oncology), and
Recce Pharmaceuticals Ltd
(1.96 million Australian Dollars [US$1.42 million]
of which 100%
was RESEARCH AND DEVVELOPMENT OF PHARMACEUTI).
Sales Analysis.
Medibio Ltd reported sales of A$1.27 million (US$917.27 thousand)
for the
fiscal
year ending
June of 2021.
This
represents
an
increase of 35.7%
versus 2020, when the company's sales were A$932,831.00 .
Despite this increase, sales are still
well
below the level achieved in 2019, when Medibio Ltd
reported sales of A$4.13 million.